Reasons for substance use in schizophrenia

Acta Psychiatrica Scandinavica
Jean Addington, V Duchak

Abstract

Abuse of and dependence on drugs, alcohol and other substances in schizophrenia are being increasingly recognized and well documented in the literature. It has been suggested that up to 60% of patients with schizophrenia use illicit drugs. A total of 41 subjects who fulfilled DSM-III-R criteria for schizophrenia and substance abuse or dependence were asked to describe their reasons for using such substances, the reasons why they might stop and the subjective effects of the substances. Drugs were reportedly used to increase pleasure, to 'get high' and to reduce depression. However, subjective effects of increased depression and positive symptoms were also reported. These results are considered in the context of potential treatment strategies.

References

Jul 18, 2009·European Archives of Psychiatry and Clinical Neuroscience·Deepak Cyril D'SouzaMohini Ranganathan
Jul 6, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·P Batel
Aug 5, 2004·The American Journal of Orthopsychiatry·Alexandra B LaudetEdward L Knight
May 14, 2008·The Australian and New Zealand Journal of Psychiatry·Martin CohenVaughan Carr
Nov 19, 2008·The Australian and New Zealand Journal of Psychiatry·Michael SchaubRudolf Stohler
Feb 16, 2010·Journal of Addictive Diseases·Natascha Wilson, Jean Lud Cadet
Jun 5, 2013·Social Work in Public Health·Kim T Mueser, Susan Gingerich
Aug 30, 2008·Schizophrenia Bulletin·Cécile HenquetRobin M Murray
Sep 20, 2005·The Australian and New Zealand Journal of Psychiatry·Sharon Lawn, Rene Pols
Nov 26, 2010·BMC Psychiatry·Carolyn J Asher, Linda Gask
Dec 17, 2009·The Australian and New Zealand Journal of Psychiatry·Bart D PetersL de Haan
Dec 29, 2013·International Journal of Qualitative Studies on Health and Well-being·Henning PettersenAnne Landheim
May 20, 2014·Psychiatry Journal·Rudraprosad ChakrabortySuprakash Chaudhury
Jun 25, 2014·Molecular Psychiatry·R A PowerN G Martin
Dec 27, 2011·Addictive Behaviors·L K ThorntonM P Johnson
Dec 22, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Anna KolliakouRobin M Murray
Dec 5, 2008·Psychiatry Research·Jacopo V BizzarriGiovanni Battista Cassano
Jan 24, 2007·Clinical Psychology Review·Lynsey GreggGillian Haddock
May 10, 2005·Acta Psychiatrica Scandinavica. Supplementum·L van NimwegenD Linszen
Sep 14, 2006·Acta Psychiatrica Scandinavica·R KilianK Frasch
Aug 1, 2008·Early Intervention in Psychiatry·Leanne HidesAlison R Yung
Feb 1, 2008·Early Intervention in Psychiatry·Alissa Pencer, Jean Addington
Jul 31, 2013·Psychiatry and Clinical Neurosciences·Patrizia Thoma, Irene Daum
Apr 11, 2012·Acta Psychiatrica Scandinavica·L K ThorntonT J Lewin
Sep 26, 2006·Addictive Behaviors·Asa ErikssonSheilagh Hodgins
Jun 6, 2006·Schizophrenia Research·A TalamoR J Baldessarini
Aug 31, 2001·Biological Psychiatry·R A ChambersD W Self
Nov 28, 2013·Early Intervention in Psychiatry·Kelly E GillCheryl M Corcoran
Aug 28, 2012·Psychiatry Research·Gina M NajoliaAlex S Cohen
Jul 23, 2011·Schizophrenia Research·Clifford M CassidyAshok K Malla
Mar 23, 2010·Schizophrenia Research·Lorena Jiménez-CastroMichael Escamilla
May 6, 2014·Consciousness and Cognition·Cory J GerritsenJohn Eastwood
Dec 18, 2014·Asian Journal of Psychiatry·Nopporn Tantirangsee, Sawitri Assanangkornchai

Citations

Dec 1, 1992·Journal of Consulting and Clinical Psychology·Kim T MueserJ J Blanchard
Jul 1, 1991·The Journal of Nervous and Mental Disease·D L NoordsyT S Paskus
Jul 1, 1989·The Journal of Nervous and Mental Disease·R E DrakeM A Wallach
Jan 1, 1989·Schizophrenia Bulletin·M A TestK Ripp
Nov 1, 1987·The Journal of Nervous and Mental Disease·F R Schneier, S G Siris
Aug 1, 1986·Psychological Medicine·J C NegreteW B Smith
Feb 1, 1984·Acta Psychiatrica Scandinavica·P Knudsen, T Vilmar

Related Concepts

Schizophrenia
Recreational Drugs
Alcohol-Related Disorders
Schizophrenic Psychology
Factor Construct Rating Scales (Fcrs)
Motivation
Substance-Related Disorders
Illicit Drugs
Psychotropic Drugs

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Related Papers

The American Journal on Addictions
Santanu GoswamiGagandeep Singh
The Australian and New Zealand Journal of Psychiatry
Michael SchaubRudolf Stohler
Early Intervention in Psychiatry
Alissa Pencer, Jean Addington
© 2020 Meta ULC. All rights reserved